Compounds > torpedo
Page last updated: 2024-08-23

torpedo and transforming growth factor beta

torpedo has been researched along with transforming growth factor beta in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, S; Li, H; Link, H; Ljunggren, HG; Shi, FD; Taniguchi, M; Van Kaer, L; Wang, HB1
Mozes, E; Paas-Rozner, M; Sela, M1
Duan, RS; Link, H; Scallon, B; Wang, HB; Xiao, BG; Yang, JS1
Aruna, BV; Mozes, E; Sela, M1
Ben-David, H; Dayan, M; Mozes, E; Sela, M; Sharabi, A1

Other Studies

5 other study(ies) available for torpedo and transforming growth factor beta

ArticleYear
Natural killer cells determine the outcome of B cell-mediated autoimmunity.
    Nature immunology, 2000, Volume: 1, Issue:3

    Topics: Amino Acid Sequence; Animals; Antibody Formation; Autoantibodies; Autoimmunity; B-Lymphocytes; Female; Immunization; Inbreeding; Interferon-gamma; Interleukin-8; Killer Cells, Natural; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Myasthenia Gravis, Autoimmune, Experimental; Receptors, Nicotinic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta

2000
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Oct-23, Volume: 98, Issue:22

    Topics: Amino Acid Sequence; Animals; Cytokines; Female; Immunization; Interleukin-2; Interleukin-4; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Myasthenia Gravis; Peptide Fragments; Receptors, Cholinergic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta

2001
Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis.
    Journal of autoimmunity, 2002, Volume: 19, Issue:4

    Topics: Animals; Antibodies; Disease Models, Animal; Down-Regulation; Female; Interferon-gamma; Interleukin-10; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Receptors, Nicotinic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2002
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells.
    Journal of neuroimmunology, 2006, Volume: 177, Issue:1-2

    Topics: Animals; Autoimmunity; Biomarkers; CD4-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Down-Regulation; Female; Immunosuppression Therapy; Interleukin-10; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myasthenia Gravis, Autoimmune, Experimental; Peptides; Receptors, Interleukin-2; Receptors, Nicotinic; Subcellular Fractions; Torpedo; Transforming Growth Factor beta; Treatment Outcome; Up-Regulation

2006
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Oct-30, Volume: 104, Issue:44

    Topics: Animals; bcl-X Protein; Caspase 3; Caspase 8; CD28 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Down-Regulation; Female; Forkhead Transcription Factors; Immunization; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Ligands; Mice; Mice, Knockout; Myasthenia Gravis; Peptides; Receptors, Nicotinic; Torpedo; Transforming Growth Factor beta; Up-Regulation

2007